Skip to main content

Table 3 Study outcomes

From: INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer’s Symptomatic Expression (INCREASE), a randomized controlled trial: rationale, study design, and protocol

Study outcomes

Primary

Medication appropriateness

MAI

Change from pre- to post-intervention

Executive function

TMTB

CRCS: difference in scopolamine-challenged and unchallenged z-scores

Secondary

Global cognition

MoCA

Memory

CVLT

Perceived health status

SF-36

Change from pre- to post-intervention

  1. MAI medication appropriateness index, TMTB Trail Making Test B, CVLT California Verbal Learning Test, MoCA Montreal Cognitive Assessment, SF-36 Short-Form 36